Biosimulation Market is estimated to reach a market size worth US$14.068 billion by 2026

Knowledge Sourcing Intelligence launches the publication of a new report on “Biosimulation Market – Forecasts from 2019 to 2026” to their giving.

The prime factors driving the growth of the bio-simulation market are the surging demand for the pharmaceutical industry for growing diseases and their variations.

As per the report, the market for Biosimulation Market is expected to grow at a steady pace.

Bio-simulations are computer-aided programs that can stimulate biological processes and systems. The technology is widely used in the pharmaceutical sector to mimic the flow of disease studied and observe the impact of the designed medicine on the simulate and body. Intensive investment in R&D will significantly boost the market. However, a lack of standardization in bio-simulation may hinder market growth.

The bio-simulation market is segmented, based on type, into software and services. Bio-simulation software has a considerable market size. Based on the application of the simulates, the market is segmented into drug development, drug discovery, and others.

Based on end-user, the bio-simulation market is fragmented as a pharmaceutical company, academic institutes, research organizations, and others. Pharmaceutical bio-simulation demand will dominate the market during the forecasted period.  

Based on geography, the bio-simulation market is segmented into the North American region, the South American region, the Middle East and African region, the European region, and the Asia Pacific region. The North American bio-simulation market shows promising growth during the forecasted period owing to the surging growth of the biotechnology and pharmaceutical industries.

The coronavirus pandemic had a positive impact on the bio-simulation market. the emergency of the virus resulted in the increasing adoption of the technology for devising vaccines by pharmaceutical companies and academic institutes.

As a part of the report, the major players operating in the bio-simulation market, that have been covered are Rhenovia Pharma, Accelrys, Certara, Genedata, Leadscope, Compugen, Archimedes, Simulations Plus Inc., Schrodinger Inc., and Insilico biotechnology.

View a sample of the report or purchase the complete study at

This analytics report segments the bio-simulation market on the following basis

  • By Type
    • Software
    • Services
  • By End-users
    • Pharmaceuticals Company
    • Academic Institutions
    • Research Organizations
    • Others
  • By Application
    • Drug Development
    • Drug Discovery
    • Others
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • Germany
      • France
      • United Kingdom
      • Spain
      • Others
    • The Middle East and Africa
      • Saudi Arabia
      • South Africa
      • Others
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Others